Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.
The approval was granted by Agenzia Italiana del Farmaco
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Subscribe To Our Newsletter & Stay Updated
